Skip to main content
23 November 2024
Last updated:
Friday 22 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Setting the pace in radiopharmaceutical development
Read more
New opportunities for small molecules in cancer
Read more
Swiss companies weather the turmoil in 2022
Read more
Capturing the promise of p38 MAPK inhibition
Read more
Destiny Pharma advances strategy against bacteria
Read more
Adrenomed prepares global study in septic shock
Read more
Microbiome-based therapies as anti-cancer agents
Read more
Antibody-drug conjugates come to the fore
Read more
Antimicrobial Review: New research, new payment models
Read more
Cancer Research UK has new model
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
